Heparanase 2 and Urofacial Syndrome, a Genetic Neuropathy
- PMID: 32274739
- DOI: 10.1007/978-3-030-34521-1_35
Heparanase 2 and Urofacial Syndrome, a Genetic Neuropathy
Abstract
Urofacial syndrome (UFS) is a rare but potentially devastating autosomal recessive disease. It comprises both incomplete urinary bladder emptying and a facial grimace upon smiling. A subset of individuals with the disease has biallelic mutations of HPSE2, coding for heparanase-2. Heparanase-2 and the classical heparanase are both detected in nerves in the maturing bladder, and mice mutant for Hpse2 have UFS-like bladder voiding defects and abnormally patterned bladder nerves. Other evidence suggests that the heparanase axis plays several roles in the peripheral and central nervous systems, quite apart from UFS-related biology. Some individuals with UFS lack HPSE2 mutations and instead carry biallelic variants of LRIG2, encoding leucine-rich-repeats and immunoglobulin-like-domains 2. Like heparanase-2, LRIG2 is detected in bladder nerves, and mutant Lrig2 mice have urination defects and abnormal patterns of bladder nerves. Further work is now needed to define the precise roles of heparanase-2 and LRIG2 in normal and abnormal neural differentiation.
Keywords: Autonomic; Bladder; HPSE2; LRIG2; Nerve; Urinary; Voiding.
Similar articles
-
Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder.Kidney Int. 2019 May;95(5):1138-1152. doi: 10.1016/j.kint.2018.11.040. Epub 2019 Mar 8. Kidney Int. 2019. PMID: 30885509 Free PMC article.
-
Urinary tract effects of HPSE2 mutations.J Am Soc Nephrol. 2015 Apr;26(4):797-804. doi: 10.1681/ASN.2013090961. Epub 2014 Aug 21. J Am Soc Nephrol. 2015. PMID: 25145936 Free PMC article.
-
LRIG2 mutations cause urofacial syndrome.Am J Hum Genet. 2013 Feb 7;92(2):259-64. doi: 10.1016/j.ajhg.2012.12.002. Epub 2013 Jan 11. Am J Hum Genet. 2013. PMID: 23313374 Free PMC article.
-
Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation.Pediatr Nephrol. 2014 Apr;29(4):513-8. doi: 10.1007/s00467-013-2552-2. Epub 2013 Jul 9. Pediatr Nephrol. 2014. PMID: 23832138 Review.
-
Clinical and genetic characteristics for the Urofacial Syndrome (UFS).Int J Clin Exp Pathol. 2014 Apr 15;7(5):1842-8. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966895 Free PMC article. Review.
Cited by
-
A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane.Front Oncol. 2021 Apr 20;11:645524. doi: 10.3389/fonc.2021.645524. eCollection 2021. Front Oncol. 2021. PMID: 33959505 Free PMC article.
-
Expanding the HPSE2 Genotypic Spectrum in Urofacial Syndrome, A Disease Featuring a Peripheral Neuropathy of the Urinary Bladder.Front Genet. 2022 Jun 23;13:896125. doi: 10.3389/fgene.2022.896125. eCollection 2022. Front Genet. 2022. PMID: 35812751 Free PMC article.
-
Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis.Cell Death Dis. 2024 Mar 22;15(3):232. doi: 10.1038/s41419-024-06596-8. Cell Death Dis. 2024. PMID: 38519456 Free PMC article.
-
Human HPSE2 gene transfer ameliorates bladder pathophysiology in a mutant mouse model of urofacial syndrome.Elife. 2024 Jul 11;13:RP91828. doi: 10.7554/eLife.91828. Elife. 2024. PMID: 38990208 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources